(Reuters) - Johnson & Johnson reported better-than-expected fourth-quarter earnings on Tuesday, but took another big special charge for its recalled artificial hips and forecast 2013 earnings below Wall Street forecasts. The diversified healthcare company said it earned $2.6 billion (1.6 billion pounds), or 91 cents per share. ...
This entry was posted
on Tuesday, January 22nd, 2013 at 1:36 pm and is filed under Market News.
You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.
